首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >In silico identification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moiety
【2h】

In silico identification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moiety

机译:在计算机上鉴定和无P1天冬氨酸部分的caspase-3抑制剂的晶体结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Using a fragment-based docking procedure, several small-molecule inhibitors of caspase-3 were identified and tested and the crystal structures of three inhibitor complexes were determined. The crystal structures revealed that one inhibitor (NSC 18508) occupies only the S1 subsite, while two other inhibitors (NSC 89167 and NSC 251810) bind only to the prime part of the substrate-binding site. One of the major conformational changes observed in all three caspase-3–inhibitor complexes is a rotation of the Tyr204 side chain, which blocks the S2 subsite. In addition, the structural variability of the residues shaping the S1–S4 as well as the S1′ subsites supports an induced-fit mechanism for the binding of the inhibitors in the active site. The high-resolution crystal structures reported here provide novel insights into the architecture of the substrate-binding site, which might be useful for the design of more potent caspase inhibitors.
机译:使用基于片段的对接程序,鉴定并测试了几种caspase-3小分子抑制剂,并确定了三种抑制剂复合物的晶体结构。晶体结构表明,一种抑制剂(NSC 18508)仅占据S1亚位点,而其他两种抑制剂(NSC 89167和NSC 251810)仅与底物结合位点的主要部分结合。在所有三个caspase-3抑制剂复合物中观察到的主要构象变化之一是Tyr204侧链旋转,该旋转阻断了S2亚位点。此外,形成S1-S4以及S1'子位点的残基的结构变异性支持了诱导剂与活性位点结合的机制。本文报道的高分辨率晶体结构为底物结合位点的结构提供了新颖的见解,这可能对设计更有效的半胱天冬酶抑制剂有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号